意大利接受积极抗肿瘤治疗的患者中 SARS-CoV-2 感染的发生率。
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy.
机构信息
Medical Oncology Unit, Department of Oncology, Ospedale Sant'Andrea, La Spezia, Italy.
Department of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
出版信息
JAMA Oncol. 2021 Feb 1;7(2):304-306. doi: 10.1001/jamaoncol.2020.6778.
Abstract
This cohort study examines rates of SARS-CoV-2 infection among patients with cancer receiving antitumor treatment.
摘要
本队列研究考察了接受抗肿瘤治疗的癌症患者中 SARS-CoV-2 感染的发生率。
相似文献
1
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy.意大利接受积极抗肿瘤治疗的患者中 SARS-CoV-2 感染的发生率。
JAMA Oncol. 2021 Feb 1;7(2):304-306. doi: 10.1001/jamaoncol.2020.6778.
2
Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors?疫情期间肿瘤患者的远程肿瘤学或远程医疗：乳腺癌幸存者的新常态？
Future Oncol. 2020 Oct;16(28):2191-2195. doi: 10.2217/fon-2020-0714. Epub 2020 Aug 28.
3
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.COVID-19 疫情对意大利癌症免疫治疗的影响：对年轻肿瘤学家的调查。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001154.
4
Update in oncology.
Ann Intern Med. 2005 Oct 18;143(8):587-92. doi: 10.7326/0003-4819-143-8-200510180-00009.
5
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).新冠肺炎疫情期间乳腺癌管理的变化：欧洲乳腺癌研究协会外科试验员（EUBREAST）的国际调查。
Breast. 2020 Aug;52:110-115. doi: 10.1016/j.breast.2020.05.006. Epub 2020 May 29.
6
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).雄激素剥夺疗法治疗前列腺癌与 SARS-CoV-2 感染风险的关系：一项基于人群的研究（N=4532）。
Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6.
7
Chemotherapy principles for breast, prostate, colon and lung cancer.
S D Med. 2010;Spec No:52-6.
8
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.意大利两个 SARS-CoV-2 感染高发地区癌症中心的数据为 COVID-19 大流行期间接受免疫治疗的局部晚期和转移性黑色素瘤患者的成功管理提供了证据。
Semin Oncol. 2020 Oct;47(5):302-304. doi: 10.1053/j.seminoncol.2020.07.010. Epub 2020 Aug 7.
9
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.在新冠疫情期间，类似新冠病毒感染的检查点抑制剂肺炎。
Lung Cancer. 2020 Aug;146:376-377. doi: 10.1016/j.lungcan.2020.06.013. Epub 2020 Jun 17.
10
Current cancer profiles of the Italian regions: should cancer incidence be monitored at a national level?意大利各地区当前的癌症概况：是否应在国家层面监测癌症发病率？
Tumori. 2007 Nov-Dec;93(6):529-31. doi: 10.1177/030089160709300601.
引用本文的文献
1
The impact of the COVID-19 pandemic on the small cell lung cancer epidemiology.2019年冠状病毒病大流行对小细胞肺癌流行病学的影响。
Discov Oncol. 2025 Jun 9;16(1):1037. doi: 10.1007/s12672-025-02816-5.
2
COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study.新冠病毒疫苗接种与晚期非小细胞肺癌患者抗程序性死亡受体-（配体）1免疫治疗疗效增强相关：一项真实世界研究
Infect Agent Cancer. 2023 Sep 7;18(1):50. doi: 10.1186/s13027-023-00526-7.
3
The Interplay of Lung Cancer, COVID-19, and Vaccines.肺癌、COVID-19 和疫苗的相互作用。
Int J Mol Sci. 2022 Dec 1;23(23):15067. doi: 10.3390/ijms232315067.
4
Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis.感染新型冠状病毒2的患者中的结直肠癌：一项系统综述和荟萃分析。
Infect Agent Cancer. 2022 Sep 12;17(1):49. doi: 10.1186/s13027-022-00459-7.
5
Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study).安道尔公国癌症患者接种疫苗前后的血清流行率研究（COVONCO 研究）。
J Cancer Res Clin Oncol. 2023 Jul;149(7):2883-2892. doi: 10.1007/s00432-022-04141-8. Epub 2022 Jul 9.
6
Safety and Feasibility of Lung Cancer Surgery under the COVID-19 Circumstance.COVID-19疫情下肺癌手术的安全性与可行性
Cancers (Basel). 2022 Mar 4;14(5):1334. doi: 10.3390/cancers14051334.
7
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease.患者视角：新型冠状病毒肺炎与神经内分泌肿瘤疾病
Cancers (Basel). 2022 Jan 26;14(3):613. doi: 10.3390/cancers14030613.
8
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.肺癌与严重急性呼吸综合征冠状病毒 2 感染：确定重要的研究知识空白。
J Thorac Oncol. 2022 Feb;17(2):214-227. doi: 10.1016/j.jtho.2021.11.001. Epub 2021 Nov 10.
9
Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis.先前接触免疫检查点抑制剂治疗是否会影响癌症患者 COVID-19 的发病率和死亡率：系统评价和荟萃分析。
Int Immunopharmacol. 2021 Dec;101(Pt A):108242. doi: 10.1016/j.intimp.2021.108242. Epub 2021 Oct 11.
10
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment.癌症患者在积极治疗过程中针对 COVID-19 感染和/或疫苗的血清学反应。
ESMO Open. 2021 Dec;6(6):100283. doi: 10.1016/j.esmoop.2021.100283. Epub 2021 Sep 27.
Zotero 插件